financetom
Business
financetom
/
Business
/
Volkswagen draws on Valeo, Mobileye for driving assistance push
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Volkswagen draws on Valeo, Mobileye for driving assistance push
Mar 25, 2025 2:12 AM

March 25 (Reuters) - Volkswagen Group said on

Tuesday it would collaborate with Valeo and Mobileye

as it deepens its network of suppliers to develop

assisted and autonomous driving.

The German carmaker said in a statement it will draw on the

suppliers' capabilities for enhanced partially automated

driving, known as Level 2+ systems, for security and driver

comfort in new high-volume models over the next few years.

In 2022, Volkswagen signed up Bosch to co-develop software

for different levels of automated driving.

In its statement on Tuesday, VW said Valeo would provide

electronic control units, sensors and parking solutions, with

Mobileye contributing camera, radar and mapping technologies.

The targeted features include hands-free driving under

specific conditions, traffic jam assist, hazard detection,

parking assist and driver monitoring.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Akoya Biosciences Spatial Proteomics Platform to be Used in Cancer Immunotherapy Consortium
Akoya Biosciences Spatial Proteomics Platform to be Used in Cancer Immunotherapy Consortium
Oct 7, 2024
11:20 AM EDT, 10/07/2024 (MT Newswires) -- Akoya Biosciences ( AKYA ) said Monday that its spatial proteomics platforms will be used to analyze tissue samples as part of the Multiomic Analysis of Immunotherapy Features Evidencing Success and Toxicity, or MANIFEST, program. The initiative, funded by the UK Office of Life Sciences and the Medical Research Council, seeks to enhance...
ViiV Healthcare Aims to Provide At Least 2 Million Doses of HIV PrEP to Low, Middle-Income Countries
ViiV Healthcare Aims to Provide At Least 2 Million Doses of HIV PrEP to Low, Middle-Income Countries
Oct 7, 2024
11:20 AM EDT, 10/07/2024 (MT Newswires) -- ViiV Healthcare said Monday it is committed to providing at least two million doses of long-acting cabotegravir for HIV pre-exposure prophylaxis to low- and middle-income countries over the next two years. ViiV Healthcare is majority-owned by GSK (GSK) and has Pfizer ( PFE ) and Shionogi as shareholders. The company said its available...
Trinity Biotech Says CGM Trial Validates Sensor Enhancements; Shares Rise
Trinity Biotech Says CGM Trial Validates Sensor Enhancements; Shares Rise
Oct 7, 2024
11:19 AM EDT, 10/07/2024 (MT Newswires) -- Trinity Biotech ( TRIB ) shares rose 9% in recent trading Monday after the company said its first pre-pivotal clinical trial in Europe for its next-generation continuous glucose monitor, or CGM, confirmed that the refined sensor achieved a mean absolute relative difference comparable to previous models. The outcome validates the enhancements made since...
Vale Flags Temporary Interruption of Operations at Nickel Plant Following Power Disruption
Vale Flags Temporary Interruption of Operations at Nickel Plant Following Power Disruption
Oct 7, 2024
11:22 AM EDT, 10/07/2024 (MT Newswires) -- Vale (VALE) said Sunday that electricity issues caused a temporary interruption of operations at its Onca Puma nickel plant in Brazil's Para state. The miner said strong winds on Saturday damaged the local electricity provider's transmission network and the network is expected to be restored on Oct. 15. Vale said it will assess...
Copyright 2023-2026 - www.financetom.com All Rights Reserved